PropertyValue
?:abstract
  • Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is currently in a pandemic outbreak and has become a global health issue. In addition to primarily involving the respiratory system, myocarditis is considered an important and fatal lesion in patients with COVID-19. However, effective therapeutic methods are currently lacking. The cholinergic anti-inflammatory pathway (CAP) has been demonstrated to suppress pro-inflammatory cytokine production and control inflammation in sepsis and other medical conditions. Therefore, the CAP may be a potential and effective therapeutic method for COVID-19-related myocarditis. This article reviews the relationship between COVID-19-related myocarditis and the CAP and discusses the CAP as a potential therapeutic modality in the treatment of COVID-19-related myocarditis.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.hjc.2020.12.004
?:doi
?:journal
  • Hellenic_J_Cardiol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/d72cd8517a8b8414364032da72e0e2fd1c8d51d3.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7722500.xml.json
?:pmcid
?:pmid
?:pmid
  • 33301863.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • COVID-19-related myocarditis and cholinergic anti-inflammatory pathways
?:type
?:year
  • 2020-12-08

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/0plenbp5>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/0plenbp5>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all